Since the early 1950s, management of ovarian insufficiency and failure, including infertility caused by aging or insults, was restricted by the belief that the oocyte-containing pool of follicles set forth at birth is not amenable to renewal 1 . In 2004, studies with mice challenged the idea of a fixed ovarian reserve being endowed during the perinatal period 2 . Based on results from several approaches, it was concluded that the ovaries of adult mice possess rare female germline or oogonial stem cells (OSCs) that generate oocytes in a way analogous to the spermatogonial stem cell support of sperm production in adult testes 3 . Although this previous study was criticized by many in the field 4 , several years later OSCs were successfully isolated from neonatal and adult mouse ovaries. The cells were shown to stably proliferate in vitro for months 5, 6 and spontaneously generate what seem to be immature oocytes in culture 6 . Transplantation studies showed that GFP-expressing mouse OSCs injected into ovaries of chemotherapy-conditioned adult mice differentiate into mature eggs that are ovulated, fertilize and produce viable offspring 5 . These findings, along with other studies of mice 7-9 , have opened the possibility of using OSCs as agents for transplantation and targets for therapies designed to modulate ovarian function and fertility 4,10 . Additionally, identification of dormant OSCs in atrophic ovaries of aged mice, which resume in vivo oogenesis when exposed to a youngadult (2 months of age) ovarian environment 11 , indicates that ovarian aging may be reversible 10, 12 . However, any consideration of a possible clinical utility of these cells requires firm evidence that comparable oocyte-producing cells exist in ovaries of reproductive-age women.
Since the early 1950s, management of ovarian insufficiency and failure, including infertility caused by aging or insults, was restricted by the belief that the oocyte-containing pool of follicles set forth at birth is not amenable to renewal 1 . In 2004, studies with mice challenged the idea of a fixed ovarian reserve being endowed during the perinatal period 2 . Based on results from several approaches, it was concluded that the ovaries of adult mice possess rare female germline or oogonial stem cells (OSCs) that generate oocytes in a way analogous to the spermatogonial stem cell support of sperm production in adult testes 3 . Although this previous study was criticized by many in the field 4 , several years later OSCs were successfully isolated from neonatal and adult mouse ovaries. The cells were shown to stably proliferate in vitro for months 5, 6 and spontaneously generate what seem to be immature oocytes in culture 6 . Transplantation studies showed that GFP-expressing mouse OSCs injected into ovaries of chemotherapy-conditioned adult mice differentiate into mature eggs that are ovulated, fertilize and produce viable offspring 5 . These findings, along with other studies of mice [7] [8] [9] , have opened the possibility of using OSCs as agents for transplantation and targets for therapies designed to modulate ovarian function and fertility 4, 10 . Additionally, identification of dormant OSCs in atrophic ovaries of aged mice, which resume in vivo oogenesis when exposed to a youngadult (2 months of age) ovarian environment 11 , indicates that ovarian aging may be reversible 10, 12 . However, any consideration of a possible clinical utility of these cells requires firm evidence that comparable oocyte-producing cells exist in ovaries of reproductive-age women.
As a first step toward this goal, we critically assessed a recently reported protocol to obtain OSCs from adult mouse ovaries 5 . This approach relies on the immunological detection of a putative cellsurface variant of Ddx4 (DEAD box polypeptide 4, also commonly referred to as mouse vasa homolog or Mvh), an evolutionarily conserved germ-cell-specific RNA helicase [13] [14] [15] , coupled with cell sorting using magnetic beads. Two issues surfaced that we felt might preclude application of this protocol to isolate candidate OSCs from adult human ovaries. First, Ddx4 is widely considered to be a cytoplasmic protein and, thus, its reported detection on the surface of mouse OSCs is at odds with the results from prior studies 10, 16 . Second, even if a cell-surface variant of Ddx4 is expressed by mouse OSCs, immunomagnetic sorting is a relatively crude approach to cell isolation that often results in the enrichment of a desired cell type in fractions that are contaminated with non-targeted cells carried over during the column washing and flushing steps. Magnetic bead sorting also does not distinguish between viable and damaged or dead cells and does not allow for simultaneous assessment of other cellular features, such as yield, size or co-expression of additional markers. Our objectives were to initially test with mice whether or not OSCs possess an externally exposed epitope of Ddx4 and, if so, to use this property for validation of a fluorescence-activated cell sorting (FACS)-based protocol to purify viable OSCs from the dispersed ovaries of adult mice. We next determined whether this technology could also be used to purify an equivalent population of candidate OSCs from the ovarian cortical tissue of healthy reproductive-age women. Once we isolated mouse and human OSCs by FACS, we then tested their growth properties and functionality using both in vitro and in vivo approaches.
RESULTS

Validation of a FACS-based protocol for OSC isolation
The antibody to Ddx4 used previously to isolate mouse OSCs by immunomagnetic sorting is a rabbit polyclonal antibody against the a r t i c l e s 4 1 4 VOLUME 18 | NUMBER 3 | MARCH 2012 nature medicine C terminus of the protein (hereafter called the COOH antibody) 5 . We obtained this antibody, along with a goat polyclonal antibody against the N terminus of Ddx4 (hereafter called the NH 2 antibody), for our comparative studies. An immunofluorescence analysis of ovaries from young-adult mice using either of the two antibodies showed an identical pattern of Ddx4 expression that was restricted to the oocytes (Fig. 1a) . We then used each antibody for immunomagnetic sorting of dispersed ovary tissue from young-adult mice 5 . We obtained no cells in the bead fraction when we used the NH 2 antibody; however, we observed 5-to 8-µm cells bound to the magnetic beads when we used the COOH antibody (Fig. 1b) . An analysis of the cells isolated with the COOH antibody revealed a germline gene expression pattern consistent with that previously reported for mouse OSCs isolated using immunomagnetic sorting 5 ( Supplementary Fig. 1 ). Although we always detected the isolated oocytes in the non-immunoreactive wash fraction using the COOH antibody when assessed in parallel (Fig. 1b) , a more thorough marker analysis of the Ddx4-positive viable cell fraction obtained by immunomagnetic sorting revealed several oocyte-specific mRNAs, including mRNA of the Nobox (newborn ovary homeobox), Zp3 (zona pellucida glycoprotein 3) and Gdf9 (growth differentiation factor 9) genes (Supplementary Fig. 1 ). These findings indicate that although mouse oocytes do not show evidence of cell-surface expression of Ddx4 when analyzed as individual entities (Fig. 1b) , mouse oocytes are nonetheless a contaminating cell type after immunomagnetic sorting of OSCs from dispersed mouse ovary tissue. This outcome probably reflects either a non-specific physical carryover of small oocytes with OSCs during column washing and flushing or a reactivity of cytoplasmic Ddx4 in plasma-membranecompromised (damaged) oocytes with the COOH antibody. Therefore, we next tested the reactivity of each of the two antibodies with dispersed mouse ovarian cells by FACS. In agreement with the results from the magnetic bead sorting, we only obtained viable Ddx4-positive cells when we used the COOH antibody (Fig. 1c) . However, if we fixed and permeabilized the ovarian cells before FACS, we also obtained Ddx4-positive cells using the NH 2 antibody (Fig. 1c) . Furthermore, if we fixed, permeabilized and re-sorted the viable Ddx4-positive cells that we isolated by FACS using the COOH antibody, the same cell population was also recognized by the NH 2 antibody (Fig. 1d) . As a final means to confirm the validity of this OSC isolation method (Fig. 1e) (Fig. 1f) . Although FACS-sorted Ddx4-positive cells expressed all germline markers, we detected no oocyte markers in these cells (Fig. 1f) . Thus, unlike the oocyte contamination observed when we isolated OSCs by immunomagnetic sorting using the Ddx4 COOH antibody ( Supplementary Fig. 1 ), use of this antibody with FACS provided a strategy to obtain OSCs free of oocytes.
FACS isolation of candidate OSCs from adult human ovaries
Using the COOH antibody with FACS, we consistently isolated viable DDX4-positive cells of 5-8 µm in diameter from human ovarian cortical tissue of all subjects analyzed (n = 6), with a percent yield (1.7% ± 0.6% (mean ± s.e.m.) DDX4-positive as compared to the total viable cells sorted) that was comparable to the yield of OSCs from youngadult mouse ovaries that we processed in parallel (1.5% ± 0.2% Ddx4-positive compared to the total viable cells sorted; n = 15). The percent yield is the incidence of Ddx4-positive cells in the final pool of viable single cells sorted by FACS, which represents only a fraction of the total number of cells present in the ovaries before processing.
To estimate the incidence of OSCs per ovary, we used young-adult mice to determine the genomic DNA content per ovary (1,774.44 µg ± 426.15 µg (mean ± s.e.m.); n = 10) and divided this value into the genomic DNA content per fraction of viable cells sorted per ovary (16.41 µg ± 4.01 µg; n = 10). Assuming the genomic DNA content per cell in these mice is equivalent, this allowed us to determine how much of the total ovarian cell pool was represented by the total viable sorted cell fraction obtained after processing. Using this correction factor, we estimated the incidence of OSCs per ovary in the mice to be 0.014% ± 0.002% (0.00926 × (1.5% ± 0.2%)). The OSC yield varied across multiple replicates, but we consistently obtained between 250 to slightly over 1,000 viable Ddx4-positive cells from each youngadult mouse ovary after FACS of dispersates that we initially prepared from a pool of four young-adult mouse ovaries. Analyses of freshly isolated Ddx4-and DDX4-positive cells from mouse and human ovaries, respectively, (Fig. 2a,b) revealed similar sizes and morphology between the mouse and human cells (Fig. 2c,d ), as well as matched gene expression profiles rich in markers for early germ cells [17] [18] [19] (the markers Prdm1 and PRDM1, Dppa3 and DPPA3, Ifitm3 and IFITM3, and Tert and TERT for mice and humans, respectively; Fig. 2e ). These findings agree with the previously reported morphology and gene expression profile of mouse OSCs 5, 6 . To further define characteristic features of Ddx4-positive cells obtained from adult ovaries using FACS, we first performed an in vivo teratoma formation assay. We felt this was a crucial step, as a recent study reported the isolation of stem cells positive for Pou5f1 (POU domain class 5 transcription factor 1) from adult mouse ovaries that possess the teratoma-forming capacity of embryonic stem cells (ESCs) and induced pluripotent stem cells 20 . All (100%) of the nonobese diabetic (NOD)-severe combined immunodeficient (SCID) mice we transplanted with 1 × 10 5 mouse ESCs that we used as positive controls (n = 3) developed teratomas within 3 weeks of transplantation; however, we observed no teratomas in NOD-SCID mice that we transplanted in parallel with 1 × 10 5 Ddx4-positive cells freshly isolated from adult mouse ovaries (n = 3), even at 24 weeks after transplantation ( Fig. 2f-h ). Thus, although OSCs express numerous stem cell and primitive germ cell markers 5, 6 (Figs. 1f and 2e), these cells are distinct from the other types of pluripotent stem cells that have previously been described.
We next engineered FACS-purified mouse OSCs to express GFP using retroviral transduction after we established the cells as actively dividing germ-cell-only cultures in vitro (see below). We then used these cells to test the ability of mouse OSCs to generate oocytes after To ensure that the outcomes we obtained were reflective of the stable integration of the transplanted cells into the ovaries and also that the outcomes were not complicated by pre-transplantation-induced damage to the gonads, we injected GFP-expressing mouse OSCs into ovaries of nonchemotherapy-conditioned wild-type recipient mice at 2 months of age, and we maintained the mice for 5-6 months before analysis. At between 7 and 8 months of age, we induced the transplanted mice to ovulate using exogenous gonadotropins, after which we collected their ovaries and any oocytes released into the oviducts. We readily detected developing follicles containing GFP-positive oocytes, along with host follicles containing GFP-negative oocytes, in ovaries of all female mice that received GFP-expressing mouse OSCs that were initially purified by FACS (Fig. 3a,b) . After oviductal flushing, we observed complexes containing expanded cumulus cells surrounding centrally located oocytes both lacking and expressing GFP. Mixing these complexes with sperm from wild-type male mice resulted in fertilization and the development of preimplantation embryos, with those embryos that were derived from fertilized GFP-positive eggs retaining GFP expression through the hatching blastocyst stage (Fig. 3c-e) . From the five adult wildtype female mice transplanted with GFP-expressing OSCs 5-6 months before evaluation, we retrieved a total of 31 cumulus-oocyte complexes from the oviducts, 23 of which successfully fertilized to produce embryos. The presence of cumulus cells around each oocyte made it impossible for us to accurately determine the number of GFP-negative as compared to GFP-positive oocytes ovulated. However, an evaluation of the 23 embryos produced after in vitro fertilization (IVF) revealed that eight were GFP positive, with all five mice tested releasing at least one egg at ovulation that fertilized to produce a GFP-positive embryo. These findings indicate that mouse OSCs purified by FACS using the DDX4 COOH antibody, like their previously reported counterparts isolated from mouse ovaries by immunomagnetic sorting using the same antibody 5 , generate functional oocytes in vivo. However, our data also show that chemotherapy conditioning before transplantation is not, as previously reported 5 , required for OSCs to engraft and generate functional oocytes in adult mouse ovary tissue.
In vitro characterization of candidate human OSCs Using parameters described previously for the in vitro propagation of mouse OSCs 5 , we placed adult mouse-ovary-derived Ddx4-positive cells and adult human-ovary-derived DDX4-positive cells into defined cultures with mitotically inactive mouse embryonic fibroblasts (MEFs) as feeders. We could establish freshly isolated OSCs as clonal cell lines, and the colony formation efficiency for human OSCs not seeded onto MEFs ranged from 0.18-0.40%. We could not perform an accurate assessment of colony formation efficiency by OSCs using MEFs as initial feeders, the latter of which greatly facilitate the establishment of mouse and human OSCs in vitro. After 10-12 weeks (mouse) or 4-8 weeks (human) in culture, actively dividing germ-cell colonies became readily apparent (Supplementary Fig. 2 ). Once the OSCs were established and proliferating, the cells could be reestablished as germ-cell-only cultures in the absence of MEFs without loss of proliferative potential. A dual analysis of Ddx4 or DDX4 expression and bromodeoxyuridine (BrdU) incorporation in MEF-free cultures of mouse or human OSCs, respectively, revealed large numbers of cells double positive for Ddx4 (mouse) or DDX4 (human) and BrdU ( Fig. 4a-d) . These data confirmed that the adult mouse-and human-ovary-derived OSCs were actively dividing. At this stage, the mouse cells required passage at confluence every 4-5 d, with the cultures being split 1:6 or 1:8 (with an estimated doubling time of 14 h; Fig. 4e ). The rate of mouse OSC proliferation was approximately twofold to threefold higher than that of the human OSCs maintained in parallel, the latter of which required passage at confluence every 7 d, with cultures being split at either 1:3 or 1:4.
Cell-surface expression of Ddx4 was detectable on the surface of more than 95% of the OSCs after 18 months of propagation (Fig. 4f) . The remaining cells not positive for cell-surface expression of Ddx4 after FACS using the COOH antibody were large (up to 35 µm in diameter, with any cells >35 µm excluded prior to FACS by filtration) spherical cells spontaneously produced by OSCs during culture, which showed cytoplasmic expression of Ddx4 and will be described in detail in the next section. A gene expression analysis of the cultured cells confirmed maintenance of early germline markers (Fig. 4g) . We also detected several oocyte-specific markers in these cultures, and the importance of these data will be highlighted in the next section. To extend the mRNA analyses of Prdm1 and PRDM1, Dppa3 and DPPA3, and Ifitm3 and IFITM3, we performed an immunofluorescence analysis of these three classic primitive germline markers 17, 18 . We easily and uniformly detected all three proteins coded for by these marker genes in mouse (Fig. 4h) and human ( Fig. 4i) OSCs maintained in vitro. Notably, our detection of Ifitm3 and IFITM3 in these cells agrees with a recent study reporting that this protein can also be used to isolate OSCs from mouse ovaries by immunomagnetic bead sorting 21 .
In vitro oogenic capacity of candidate human OSCs
Consistent with results from others 6 , mouse OSCs cultured in vitro spontaneously generated large (35-50 µm in diameter) spherical cells that, by morphology ( Fig. 5a ) and gene expression analyses (Fig. 5b,c) , resembled oocytes. We observed the peak in vitro oogenesis from mouse OSCs within 24-48 h after each passage (Fig. 5d) , which was followed by a progressive decline to nearly non-detectable amounts of oogenesis each time the OSCs regained confluence. A parallel analysis of DDX4-positive cells isolated from adult human ovaries and maintained in vitro revealed that these cells, like mouse OSCs, also spontaneously generated oocytes (Fig. 5e) , as deduced from both morphological ( Fig. 5f ) and gene expression (Fig. 5c,g ) analyses. The kinetics of in-vitro oogenesis from human OSCs differed slightly from mouse OSCs in that we observed the peak oocyte formation at 72 h after each passage in human OSC cultures (Fig. 5e) , as compared to at 24-48 h in mouse OSC cultures (Fig. 5d) . In addition to detection of many widely accepted oocyte markers (Ddx4 and DDX4, Kit and KIT (the kit oncogene), Nobox and NOBOX, Lhx8 and LHX8 (LIM homeobox protein 8), Gdf9 and GDF9, as well as Zp1 and ZP1, Zp2 and ZP2, and Zp3 and ZP3 (zona pellucida glycoproteins 1-3) [22] [23] [24] [25] [26] , mouse and human OSC-derived oocytes also expressed the diplotene-stage oocyte-specific marker Ybx2 and YBX2, respectively (Y-box protein 2, also commonly referred to as Msy2 or MSY2 in mice and humans, respectively, as well as CONTRIN in humans) (Fig. 5c) , which is essential for meiotic progression and gametogenesis in both sexes 27, 28 . Using adult human ovarian cortical tissue as a positive control, we identified four commercially available antibodies against oocyte markers that specifically reacted with the immature oocytes that are present in adult human ovaries (antibodies to DDX4, KIT, YBX2 and LHX8) ( Supplementary Fig. 3) ; we also detected all four of these proteins in oocytes generated by human OSCs in vitro (Fig. 5g) .
The presence of mRNA encoding the meiotic marker YBX2 in oocytes newly formed from human OSCs in vitro prompted us to next explore the prospects of meiotic entry in these cultures. An immunofluorescence analysis of human OSCs 72 h after passage identified cells with punctate nuclear localization of the meiosis-specific DNA recombinase dosage suppressor of mck1 homolog (DMC1) and the meiotic recombination protein synaptonemal complex protein 3 (SYCP3) (Fig. 5h) . Both of these proteins are specific to germ cells and are necessary for meiotic recombination to proceed [29] [30] [31] . Furthermore, an analysis of the chromosomal DNA content of human OSC cultures 72 h after passage revealed the presence of a diploid (2n) cell population; however, we also detected peaks corresponding to 4n and 1n cell populations, the latter of which is indicative of germ cells that have reached haploid status 32 (Fig. 5i) . In the actively dividing cultures of human fibroblasts that we analyzed as controls in parallel, we detected only 2n and 4n populations of cells (Supplementary Fig. 4a ). We also detected haploid (1n) cells in mouse OSC cultures after a FACS-based chromosomal analysis (Supplementary Fig. 4b ).
Human OSCs generate oocytes in xenografted human ovary tissue
To confirm and extend the in vitro observations of oogenesis from candidate human OSCs, we stably transduced DDX4-positive cells isolated from adult human ovaries with a GFP expression vector (GFP-hOSCs) to facilitate cell tracking in two experiments. In the first experiment, we re-aggregated approximately 1 × 10 5 GFP-hOSCs with dispersed adult human ovarian cortical tissue. We observed numerous GFP-positive cells throughout the re-aggregated tissue (Fig. 6a) .
We then placed the aggregates in culture and assessed them 24-72 h later by direct (live-cell) GFP fluorescence. Within 24 h, several very large (≥50 µm) single cells had formed within the aggregates, many of which were enclosed by smaller GFP-negative cells in tightly compact structures that resembled follicles; these structures remained detectable through 72 h of culture (Fig. 6b,c) . We interpreted these findings as evidence that GFP-expressing human OSCs spontaneously generated oocytes that then became enclosed by somatic granulosa cells that were present in the adult human ovarian dispersates.
To more clearly determine whether this was indeed the case, we injected approximately 1.3 × 10 3 GFP-hOSCs into adult human ovarian cortical tissue biopsies (2 mm × 2 mm × 1 mm), which we then xenografted into NOD-SCID female mice (n = 40 total grafts). We collected the grafts after 7 d or 14 d for assessment of GFP expression. All human ovary grafts contained easily discernible primordial and primary follicles with centrally located GFP-negative oocytes. Interspersed among and often adjacent to these follicles, which were presumably present in the tissue before the injection of the GFPhOSCs, were other immature follicles containing GFP-positive oocytes (Fig. 6d,e) . A serial-section histomorphometric analysis of three randomly selected human ovarian tissue grafts injected with GFP-hOSCs revealed the presence of 15-21 GFP-positive oocytes per graft 7 d after transplantation into mice (Supplementary Fig. 5 ). As controls, we used the human ovarian cortical tissue before the injection of GFP-hOSCs (Fig. 6f ) or xenografts that received mock injections (vehicle without GFP-hOSCs) before transplantation into NOD-SCID mice (Fig. 6g) . We never detected any GFP-positive oocytes in these controls. Dual-immunofluorescence-based detection of GFP, along with either the diplotene-stage oocyte-specific marker YBX2 or the oocyte-specific transcription factor LHX8, identified many GFP-YBX2 or GFP-LHX8 double-positive cells distributed throughout the xenografts that we injected with GFP-hOSCs (Fig. 6h) . We detected no GFP-positive oocytes in human ovarian tissue before GFP-hOSC npg injection or in xenografts that did not receive GFP-hOSC injections (data not shown and Fig. 6f,g) ; however, the GFP-negative oocytes present in the tissue grafts were consistently positive for both YBX2 and LHX8 ( Fig. 6h and Supplementary Fig. 3) .
DISCUSSION
In 2004, a major paradigm shift in reproductive biology was proposed from a study in mice challenging the longstanding belief that ovaries of female mammals lose the capacity for oocyte generation before birth 2 . Although this change in thinking was initially met with resistance from some members of the scientific community because of its sharp deviation from traditional beliefs in the field 4 , subsequent studies have since independently shown that mouse OSCs can be isolated from adult ovaries for long-term propagation in vitro 5, 6 and for generation of fertilization-competent eggs in vivo after intraovarian transplantation in chemotherapy-conditioned recipient female mice 5, 21 . In addition, other work has reported that de novo oocyte formation in adult mouse ovaries can be stimulated by small-molecule inhibitors of histone deacetylases, as well as by an as-yet unidentified factor(s) in the peripheral circulation of male mice [7] [8] [9] . However, the potential clinical relevance of these findings with mice is unclear because of a lack of definitive evidence that ovaries of reproductive-age women contain a comparable population of oocyte-producing germline cells that match the characteristic features of mouse OSCs.
As a first step toward resolving this issue, we describe in detail the conceptual and technical validation of a straightforward and highly repeatable FACS-based approach for the purification of viable OSCs from adult mouse and human ovary tissue. The utility of an antibody directed against the C terminus of Ddx4 and DDX4 to isolate OSCs reflects a differentiation-dependent switch in localization of this protein in female germ cells from the cell surface (OSCs) to the cytoplasm (oocytes), with the latter being in accordance with traditional beliefs that Ddx4 and DDX4 are cytoplasmic proteins in germ cells in mice and humans, respectively. The physiological importance of this change in localization has not been determined; however, computerbased mapping of the Ddx4 and DDX4 transmembrane-spanning domain predicts that insertion of the C terminus of the protein across the cell membrane could potentially interfere with the RNA helicase domain 10, 33 . Although additional work will be needed to test this prediction, movement of proteins into and out of various cellular compartments is a post-translational mechanism that is commonly used by cells to regulate the activity of such proteins. We have incorporated this feature of Ddx4 and DDX4 into a FACS-based protocol to show that a rare population of mitotically active germ cells with (f,g) All immature follicles in human ovarian cortical tissue before GFP-hOSC injection and xenografting (f) or that received vehicle injection (no GFP-hOSCs) before xenografting (g) (negative controls) contained GFP-negative oocytes after processing for GFP detection in parallel with the samples shown. Scale bars, 25 µm. (h) Dual immunofluorescence analysis of GFP expression (green) and either the diplotene-stage oocyte-specific marker YBX2 (red) or the oocyte transcription factor LHX8 (red) in xenografts receiving GFP-hOSC injections. Note that GFP was not detected in grafts before GFP-hOSC injection, whereas YBX2 and LHX8 were detected in all oocytes before and after injection. Sections were counterstained with DAPI (blue) for the visualization of nuclei. Scale bars, 25 µm.
gene expression profiles and growth characteristics that are remarkably similar to mouse OSCs can be reliably isolated from ovaries of healthy young women and propagated long-term in vitro.
Our successful purification of what seems to be, by all criteria tested, the human equivalent of mouse OSCs was facilitated by two main factors: nearly 3 years of work in our laboratory to test and refine the protocol based on the use of antibodies to Ddx4 and DDX4 for isolation of OSCs using FACS rather than immunomagnetic sorting, as was reported initially 5 , and rare access to entire ovarian cortical tissues that had been vitrified and cryopreserved after the removal of both ovaries from women in their twenties and early thirties. Recent studies of mouse OSCs by others have showed the ability of these cells to generate immature oocytes in vitro 6 , as well as oocytes that mature into developmentally competent eggs in vivo 5 . Regarding the latter finding, it is notable that prior studies of mammalian germline stem cell transplantation using spermatogonial stem cells or OSCs have been performed with chemotherapy-conditioned hosts as recipients 5, 21, 34, 35 , presumably to open niches for effective donor-cell engraftment. Our observations show that for OSCs, adult female mice do not require chemotherapy conditioning before transplantation for these cells to effectively engraft in the ovaries and function long term (≥5 months), at least as measured by their ability to generate oocytes that mature in follicles that yield fertilization-competent eggs after ovulation. For ethical and legal reasons, as well as technical feasibility limitations related to a lack of validated protocols for efficiently maturing human primordial follicles to the antral stage in vitro for the isolation of metaphase-II oocytes, our current endpoint analysis of the equivalent cells in humans could not be as comprehensive. Nonetheless, we have established a consistent and close parallelism between human-ovaryderived DDX4-positive cells and mouse OSCs in terms of strategy of purification, yield from adult ovary tissue, morphology, primitive germline gene expression profile, in vitro growth properties, mitotic activity, meiotic activity and the ability to form oocytes in defined cultures in vitro and in injected ovary tissue in vivo.
Therefore, based on the multiple experimental lines of evidence reported herein, we feel it is reasonable to conclude that the rare cells with cell-surface expression of DDX4 that are present in the ovaries of reproductive-age women represent adult human OSCs. In addition to opening a new research field in human reproductive biology that was inconceivable less than 10 years ago, clear evidence for the existence of these cells in women may offer new opportunities to expand on and enhance current fertility-preservation strategies. For example, with assisted reproductive technologies involving cryopreservation of ovarian cortical tissue already in development for females with cancer 36, 37 , isolation and expansion of OSCs from this tissue before or after cryopreservation might be useful for new fertility applications. In fact, we found that these cells can be consistently obtained from cryopreserved and thawed human ovarian tissue samples, and that these cells per se can be cryopreserved and thawed months later with minimal loss for successful establishment in vitro. In addition, the availability of a detailed protocol for the purification of these newly discovered cells from human ovary tissue provides us and others with a much more physiologically relevant in-vitro model system from which to study human female germ cell development compared to the ESC-derived or induced pluripotent stem cell-derived germline cells that are currently used as models for human female gametogenesis [38] [39] [40] [41] [42] .
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/. 
